Corium, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage the company's broad experience with advanced transdermal and transmucosal delivery systems. Corium has developed and is the sole commercial manufacturer of seven prescription drug and consumer products with partners including Mayne Pharma and Procter & Gamble. The company has two proprietary transdermal platforms: Corplex for small molecules and MicroCor®, a biodegradable microstructure technology for small molecules and biologics, including vaccines, peptides and proteins.
| Website | http://www.corium.com |
| Revenue | $148.2 million |
| Funding | $556 million |
| Employees | View employees |
| Founded | 1999 |
| Address | 4558 50th St SE, Grand Rapids, Michigan 49512, US |
| Phone | (616) 656-4563 |
| Fax | (616) 698-5070 |
| Industry | Pharmaceuticals, Drug Delivery, Healthcare |
| Competitors | Evotec, Purdue Pharma L.P., Pacira BioSciences, Inc., Syndax Pharmaceuticals, Sientra, Inc., Clever Leaves, VIVO Cannabis Inc., HempFusion Wellness Inc., Tetra Medical Supply Corp., CURE Pharmaceutical +33 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Corium International employee's phone or email?
Corium International Questions
The Corium International annual revenue was $148.2 million in 2026.
Corium International is based in Grand Rapids, Michigan.
The NAICS codes for Corium International are [32541, 3254, 32, 325].
The SIC codes for Corium International are [28, 283].
